stockrowCardiff Oncology, Inc. (CRDF) vs Nordicus Partners Corporation (NORD)
- Cardiff Oncology, Inc. CRDF 0.80 0.00%
- Nordicus Partners Corporation NORD 3.52 +9.32%
Cardiff Oncology, Inc. and Nordicus Partners Corporation are both Biotechnology companies. Cardiff Oncology, Inc. and Nordicus Partners Corporation are of similar size ($68.4M and $62.3M). Cardiff Oncology, Inc. grew revenue faster over the last twelve months: −6.79% against −71.7%. Nordicus Partners Corporation has the higher net margin (0.00% vs −7,889.0%) and the lower return on invested capital (−4.43% vs 0.00%). Across the 17 metrics below, Nordicus Partners Corporation leads on 11 and Cardiff Oncology, Inc. on 6.
Valuation
Profitability
| Metric | CRDF | NORD | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 70.18% | 68.51% |
| Operating margin | (8,320.08%) | 0.00% | 0.00% |
| Net margin | (7,888.98%) | 0.00% | 0.00% |
| Free cash flow margin | (8,059.45%) | 0.00% | 0.00% |
| Return on equity | (94.14%) | (8.06%) | (50.82%) |
| Return on assets | (70.89%) | (6.80%) | (46.04%) |
| Return on invested capital | 0.00% | (4.43%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack